期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

丝氨酸蛋白酶SNC19及其抑制因子在胃癌中的表达 被引量：5

原文传递
导出
作者 曾蕾 曹江 张行
机构地区 浙江大学医学院附属第二医院肿瘤研究所
出处 《中华消化杂志》 CAS CSCD 北大核心 2004年第7期429-430,共2页 Chinese Journal of Digestion
基金 国家自然科学基金资助项目 ( 3 0 2 714 5 0 )
关键词 丝氨酸蛋白酶SNCl9 抑制因子 胃癌 肝细胞 肿瘤 基因表达 癌组织
分类号 R735.2 [医药卫生—肿瘤]
  • 相关文献

参考文献4

  • 1Cao J, Zheng S, Zheng L, et al. A novel serine protease SNC19 associated with human colorectal cancer. Chin Med J (Engl), 2001,114: 726-730.
  • 2Oberst MD, Johnson MD, Dickson RB, et al. Expression of the serine protease matriptase and its inhibitor HAI-I in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res, 2002, 8: 1101-1107.
  • 3Giuliettil A, Overbergh L, Valckx D, et al. An overview of realtime quantitative PCR: applications to quantify cytokine gene expression. Methods,2001, 25:386-401.
  • 4Kataoka H, Uchino H, Denda K, et al. Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa. Cancer Lett, 1998, 128: 219-227.

同被引文献72

  • 1Lei Zeng,Jiang Cao,Xing Zhang.Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract[J].World Journal of Gastroenterology,2005,11(39):6202-6207. 被引量：9
  • 2Oberst M, Anders J, Xie B, et al. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol, 2001, 158(4) :1301-1311.
  • 3Tsai WC, Sheu LF, Chao YC, et al. Decreased matriptase/HAI- 1 ratio in advanced colorectal adenocarcinoma of Chinese patients. Chin J Physiol, 2007, 50(5) :225-231.
  • 4Saleem M, Adhami VM, Zhong W,et al. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor- 1. Cancer Epidemiol Biomarkers Prev, 2006, 15 ( 2 ) : 217- 227.
  • 5Tsai WC, Chu CH, Yu CP, et al. Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women : tissue mieroarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers, 2008, 24 (2) :89-99.
  • 6Jin JS, Cheng TF, Tsai WC, et al. Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women: correlation with clinicopathological parameters. Histol Histopathol, 2007, 22 (3) :305-309.
  • 7Tsai WC, Chao YC, Lee WH, et al. Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue mieroarray analysis of immunohistochemical scores with clinicopathological parameters. Histopathology, 2006, 49(4):388-395.
  • 8Cheng MF, Tzao C, Tsai WC, et al. Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. Dis Esophagus, 2006, 19 ( 6 ) : 482- 486.
  • 9Jin JS, Hsieh DS, Loh SH, et al. Increasing expression of serine protease matriptase in ovarian tumors : tissue microarray analysis of immunostaining score with clinicopathological parameters. Mod Pathol, 2006, 19 (3) :447-452.
  • 10Vogel LK, Saebφ M, Skjelbred CF, et al. The ratio of Matriptase/ HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. BMC Cancer, 2006, 4: 61-76.

引证文献5

二级引证文献20

中华消化杂志
2004年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部